A phase 2, single-arm study of volociximab monotherapy in subjects with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer.

Trial Profile

A phase 2, single-arm study of volociximab monotherapy in subjects with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Volociximab (Primary)
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Sponsors Abbott Biotherapeutics Corp
  • Most Recent Events

    • 07 Jul 2012 Additional trial location added as reported by European Clinical Trials Database.
    • 12 Mar 2012 Additional trial location added as reported by ClinicalTrials.gov.
    • 12 Mar 2012 Actual patient number is 16 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top